Just so everyone understands as this is right from Ariad's presentations, the '113 trial will not be fully ENROLLED with PATIENTS until Q3 of 2015. This can not be approved any earlier than the first half of 2016.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.